OvaScience, Inc. of Cambridge, MA, a company, filed a Form D amendment with the SEC on 2012-07-20. The offering totals $3.6M, of which $3.6M was reported sold. Industry: Biotechnology.
Showing 25 of 39 people.
| Name | Role | Location |
|---|---|---|
| Matthew Angel | Related Person | Brisbane, CA |
| Christine Pellizzari | Related Person | Brisbane, CA |
| Michelle Dipp | Director | BOSTON, MA |
| Michelle Dipp | Executive Officer | BOSTON, MA |
| Michael W Raab | Director | South San Francisco, CA |
| Ronit W Simantov | Director | South San Francisco, CA |
| Thomas W Woiwode | Director | South San Francisco, CA |
| Geoffrey W Nichol | Director | South San Francisco, CA |
| Thomas W Dubensky | Director | South San Francisco, CA |
| Thomas W Dubensky | Executive Officer | South San Francisco, CA |
| Christine W Pellizzari | Director | South San Francisco, CA |
| Michael Raab | Related Person | Brisbane, CA |
| Stephen R Brady | Director | Seattle, WA |
| Stephen R Brady | Executive Officer | Seattle, WA |
| Harald A Stock | Director | Cambridge, MA |
| Alison A Lawton | Executive Officer | Cambridge, MA |
| Christoph A Westphal | Director | Cambridge, MA |
| Jonathan A Tilly | Director | Cambridge, MA |
| Jeff A Capello | Director | Cambridge, MA |
| Stephen A Kraus | Director | Cambridge, MA |
| Scott A Chappel | Executive Officer | Cambridge, MA |
| Christopher A Bleck | Executive Officer | Cambridge, MA |
| Richard A Aldrich | Director | Cambridge, MA |
| Thomas A Malley | Director | Cambridge, MA |
| Michael A Flanagan | Executive Officer | Boston, MA |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2026-06-23 | D | $4.1M | $4.1M |
| 2026-04-03 | D | $2.0M | $2.0M |
| 2022-05-11 | D | $15.0M | $15.0M |
| 2013-03-28 | D | $35.0M | $35.0M |
| 2012-08-14 | D/A | $4.9M | $4.9M |
| 2012-08-03 | D/A | $4.1M | $4.1M |
| 2012-07-05 | D | $1.4M | $1.4M |
| 2012-04-09 | D | $37.2M | $37.2M |